They are careful to avoid definitive statements about clinically meaningful benefits. There’s also this statement at the bottom:
Statistical Note
Unless otherwise noted, all p-values reported in this release are nominal and unadjusted for multiplicity, consistent with the exploratory, signal-finding objectives of this Phase 2 study.
I don’t like trials from publicly traded companies that don’t release much stats because it’s really hard to tell whats “genuine” and whats “make the investors happy and keep the stock prices up”.
I don’t like trials from publicly traded companies that don’t release much stats because it’s really hard to tell whats “genuine” and whats “make the investors happy and keep the stock prices up”.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
